4//SEC Filing
FLESHNER NEIL E. 4
Accession 0001104659-21-090253
CIK 0001811764other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 4:35 PM ET
Size
5.3 KB
Accession
0001104659-21-090253
Insider Transaction Report
Form 4
FLESHNER NEIL E.
DirectorChief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-07-06+25,000→ 25,000 totalExercise: $8.47Exp: 2027-07-06→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests 25% on July 6, 2022 with the remaining 75% vesting in three equal annual installments thereafter.
Documents
Issuer
POINT Biopharma Global Inc.
CIK 0001811764
Entity typeother
Related Parties
1- filerCIK 0001868209
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 4:35 PM ET
- Size
- 5.3 KB